Click here for more information about Algenuity
Click here for more information about Liqofluxphenometrics515R1
Visit cricatalyst.com!Evodos Separation Technology

Technology

New algae-delivered vaccination technology for fish

August 18, 2016
AlgaeIndustryMagazine.com

Antonio Lamb (left) and Simon Porphy Jegathese, co-founders of MicroSynbiotiX Ltd.

Antonio Lamb (left) and Simon Porphy Jegathese, co-founders of MicroSynbiotiX Ltd.

Peter O’Dwyer writes in the Irish Examiner that approximately 5% of the world’s fish stock is lost to infectious disease at a cost of more than $10+ billion annually. MicroSynbiotiX, headquartered in Cork City, Ireland, has developed an oral vaccine hidden within microalgae that fish eat, aiming to reduce those losses significantly.

“We lock the vaccine inside of the microalgae. The technology is based on feeding the vaccine locked in the microalgae to the fish and the natural digestion process of the fish unlocks the vaccine and triggers an immune response,” company co-founder Antonio Lamb said.

“The way the industry does disease management now for most aquaculture farms is that they administer a pretty excessive use of antibiotics which end up in the food, which ultimately ends up in the diets of people that eat the fish. It also gets expelled as effluents into the environment. So our technology would allow people to immunise farm-raised seafood sustainably, and vaccinate against different diseases that wipe out farms without having to use harmful antibiotics or antimicrobials,” he said.

MicroSynbiotiX was founded by Mr. Lamb, originally from Sweden, along with Simon Porphy Jegathese, from India, and native New Yorker, Sebastian Cocioba. Having participated in the IndieBio biotech accelerator in Cork, the firm has established its headquarters there, and also has lab space in California and New York.

The company’s workload will now be split into two strands with one based in Ireland and the other in the US. “We would like to do the initial strain development in the US, since we have several state-of-the-art laboratory facilities there already, and then continue that research in microalgal industrial scale-up through an Irish university gateway. We would then like to set up the industrial manufacturing and export of the product from Ireland,” Mr. Lamb said.

Read More

More Like This…

Copyright ©2010-2018 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

twittertopbarlinks_eventstopbarlinks_requesttopbarlinks_archives

From The A.I.M. Archives

— Refresh Page for More Choices
42 Technology has been appointed by LabXero, acoustic particle filtration technology company, to help develop pilot-scale biomanufacturing equipment that could significan...
JapanNews.com reports that Euglena Co., a Tokyo-based maker of nutritional supplements, is spending ¥5.8 billion ($5.3 million USD) on building a test refinery that conve...
Israeli-based Algatechnologies, Ltd. (Algatech), is teaming up with the Italian R&D company, Sphera Encapsulation S.r.l (Sphera), to develop innovative functional ingredi...
Foodbev.com reports that French marine ingredients company Algaia will install a new specialty seaweed extract unit at its facility in Brittany, France, after securing €4...
Hayley Dunning writes from the Imperial College of London that a new discovery has changed our understanding of the basic mechanism of photosynthesis and should rewrite t...
Judith Lewis Mernit writes in e360.yale.edu that an experiment being conducted by animal science professor Ermias Kebreab at the University of California, Davis, is testi...
Alexander Richter writes in thinkgeoenergy.com that Israel-based Algaennovation last week signed a 15-year contract with Icelandic energy utility and operator ON Power fo...
San Diego, CA and Kailua-Kona, HI-based Cellana, Inc. has signed an Asset Purchase Agreement with Cyanotech Corporation for the sale of Cellana’s six-acre production and ...
Cécile Barbière writes for Euractive.fr (translated by Rob Kirby) that, in large greenhouses formerly home to the tomatoes and cucumbers of the market gardening Groupe Ol...
Environmental Technology magazine notes that the difficulty in predicting how algae blooms will develop lies in their variform nature. With a multitude of different bloom...
Alexander Richter reports for Geothermal Energy News that, among the many examples offered during a recent conference in Pisa, Italy, on Perspectives and Impact of the Gr...
Nature.com reports that swimming algae have been enlisted to carry drugs to individual cells, raising the prospect that such “microswimmers” could deliver targeted therap...